The Tennessee Recovery Oriented Compliance Strategy (TN ROCS) program provides individualized treatment plans, supervision, and judicial oversight to individuals with a demonstrated need for mental health or substance use disorder treatment but do not qualify for inclusion in a drug court program.
The Tennessee Recovery Oriented Compliance Strategy (TN ROCS) program serves drug offenders who have an urgent need for treatment but do not meet the criteria to qualify for participation in a Drug Recovery Court program.
This report describes a complex care management program for pregnant women with a diagnosis of substance use disorder in Camden, New Jersey. The program, called Camden Delivers, enrolled 46 pregnant or postpartum women who were involved with the child welfare system into the care management program.
The Biden-Harris Administration’s statement of drug policy describes the 7 priorities for the first year of their administration:
This 8 page overview details strategies promoting the reunification of families when a parent has a substance use disorder. This report explains why prioritizing family unification is important and lists 10 action steps government agencies and community organizations can take to support strong, healthy families.
This 3 page briefing paper discusses the role legal aid services can play in helping address the impact of the opioid crisis on individuals, families, and communities.
This report details how the opioid crisis has affected the Hispanic/Latino population in the US. It includes data on opioid use in this community and a discussion of the socio-cultural factors associated with accessing services including facilitators and barriers to accessing appropriate prevention, treatment, and recovery services and supports.
The New Mexico statewide standing order authorizes registered pharmacists in the state to dispense naloxone to any person who uses an opioid, regardless of how the opioid is used or obtained, or to any person in a position to assist a person at risk of experiencing an opioid overdose.
The Substance Abuse and Mental Health Services Administration and the Centers for Disease Control and Prevention announced that federal funding may be used to purchase rapid fentanyl test strips (FTS). FTS can be used to determine if drugs have been cut or mixed with fentanyl which greatly increases the risk of overdose death.
In April 2021, the FDA announced approval of an application for a produce to deliver an 8 milligram (mg) dose of naloxone; previous approvals had been granted for products delivering 2 mg and 4 mg of naloxone. The approval was granted to provide an additional option for the treatment of opioid overdose.